By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cell Line Genetics will sell Ambry Genetics' StemArray aCGH product and related services under an agreement announced today.

Madison, Wis.-based CLG will sell the StemArray products and services to its current customers and other companies and research institutions. CLG will offer the StemArray services through its own labs.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new study finds that a placental protein linked with preeclampsia can be targeted by RNA silencing, according to the New Scientist.

A settlement is expected in a Duke University lawsuit hinging on using falsified data to win grants, Retraction Watch and Science report.

In PNAS this week: approach for analyzing the expression of endogenous retroviruses, circular RNAs that influence host-virus interactions, and more.

A phylogenetic analysis finds that the rare hemimastigotes form their own supra-kingdom, CBC reports.